Current Price and Market Context
As of 22 June 2026, Abbott India’s stock closed at ₹26,220.80, slightly above the previous close of ₹26,136.20. The day’s trading range was between ₹26,040.00 and ₹26,371.45, indicating limited volatility. The stock remains well below its 52-week high of ₹35,921.55, while comfortably above its 52-week low of ₹25,164.00. This price positioning suggests a consolidation phase after a significant correction from its peak levels.
Technical Trend Overview
The overall technical trend has shifted from bearish to mildly bearish, signalling a tentative stabilisation but with lingering downside risks. The daily moving averages continue to reflect a bearish stance, indicating that short-term momentum remains subdued. This is corroborated by the Bollinger Bands, which show a mildly bearish outlook on the weekly timeframe and a more pronounced bearish signal on the monthly scale, suggesting that price volatility remains skewed towards the downside in the medium term.
MACD and Momentum Oscillators
The Moving Average Convergence Divergence (MACD) indicator presents a mixed picture. On a weekly basis, the MACD is mildly bullish, hinting at some positive momentum building up in the short term. However, the monthly MACD remains mildly bearish, reflecting longer-term caution among investors. This divergence between weekly and monthly MACD readings underscores the stock’s current indecision and the potential for volatility in the coming weeks.
RSI and Relative Strength
The Relative Strength Index (RSI) does not currently provide a definitive signal on either the weekly or monthly charts. This neutral RSI reading suggests that Abbott India is neither overbought nor oversold, reinforcing the notion of a consolidation phase. Investors should monitor RSI closely for any breakout above 70 or breakdown below 30, which could indicate a shift in momentum.
Other Technical Indicators
The Know Sure Thing (KST) indicator aligns with the MACD, showing a mildly bullish trend on the weekly timeframe but a bearish stance monthly. This further emphasises the short-term optimism tempered by longer-term caution. The On-Balance Volume (OBV) indicator is mildly bearish on the weekly chart, signalling that volume trends are not strongly supporting upward price movement. Meanwhile, Dow Theory analysis reveals no clear trend on either weekly or monthly charts, highlighting the stock’s current technical uncertainty.
Comparative Performance Against Sensex
Abbott India’s recent returns have lagged behind the broader market benchmark, the Sensex. Over the past week, the stock declined by 0.20% while the Sensex gained 1.69%. The one-month performance shows a sharper divergence, with Abbott India falling 5.66% against a 2.13% rise in the Sensex. Year-to-date, the stock’s return of -9.80% closely mirrors the Sensex’s -9.88%, indicating sector-wide pressures. Over the one-year horizon, Abbott India underperformed significantly, dropping 14.84% compared to the Sensex’s 5.60% decline. However, the longer-term outlook is more favourable, with three-year and five-year returns of 13.64% and 58.84% respectively, outperforming the Sensex’s 21.58% and 46.73%. The ten-year return is particularly impressive at 497.67%, far exceeding the Sensex’s 188.45%, reflecting the company’s strong fundamental growth over the long haul.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Mojo Score and Grade Revision
Abbott India’s Mojo Score currently stands at 42.0, reflecting a cautious stance on the stock’s prospects. The recent downgrade from Hold to Sell on 12 May 2026 signals a deterioration in technical and fundamental parameters. This downgrade is consistent with the mixed technical signals and the stock’s underperformance relative to the Sensex in the short term. The mid-cap classification further emphasises the stock’s susceptibility to market volatility and sector-specific risks.
Moving Averages and Price Momentum
The daily moving averages remain bearish, with the stock trading below key averages such as the 50-day and 200-day moving averages. This positioning suggests that the prevailing momentum is negative, and any rallies may face resistance near these levels. The lack of a clear crossover in moving averages indicates that a sustained trend reversal has yet to materialise. Investors should watch for a potential golden cross or death cross formation as a signal of changing momentum.
Technical Outlook and Investor Implications
The technical landscape for Abbott India is characterised by a delicate balance between short-term bullish signals and longer-term bearish pressures. The mildly bullish weekly MACD and KST indicators offer some hope for a near-term recovery, but the monthly bearish signals and bearish moving averages caution against aggressive positioning. The neutral RSI readings further suggest that the stock is in a consolidation phase, awaiting a catalyst to define its next directional move.
Given the current technical parameters and the downgrade in Mojo Grade, investors should exercise prudence. The stock’s underperformance relative to the Sensex over recent months indicates sectoral headwinds and company-specific challenges. However, the strong long-term returns highlight the company’s resilience and growth potential, which may appeal to investors with a longer investment horizon.
Abbott India Ltd. or something better? Our SwitchER feature analyzes this mid-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Conclusion: Navigating Mixed Signals
Abbott India Ltd. currently presents a challenging technical picture for investors. The stock’s transition to a mildly bearish trend, combined with mixed signals from MACD, KST, and Bollinger Bands, suggests that momentum is fragile. While short-term indicators hint at some recovery potential, the prevailing bearish moving averages and monthly technicals counsel caution.
Investors should closely monitor key technical levels, particularly the 50-day and 200-day moving averages, alongside volume trends and momentum oscillators. A decisive break above resistance levels could signal a return to bullish momentum, while failure to hold support near ₹25,164 could trigger further downside.
Given the downgrade to a Sell rating and the mid-cap status, Abbott India may be better suited for investors with a higher risk tolerance and a long-term perspective. Those seeking more stable or technically robust opportunities in the Pharmaceuticals & Biotechnology sector might consider alternative stocks identified through comprehensive multi-parameter analyses.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
